Search

everythinglearnresearchcommunity

for

Search:↓

Cancer treatment drugs can cause permanent hair loss by damaging hair follicle stem cells, but a specific inhibitor might reverse this effect.

Certain peptides can prevent hair loss in young rats caused by a cancer drug.

PBX1 reduces aging and cell death in stem cells by boosting SIRT1 and lowering PARP1.

rRSPO1 protein boosts hair growth by activating a key signaling pathway.

RCS-01 cell therapy is safe and improves skin gene expression.

Igf1r helps regulate hair growth cycles.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

Tofacitinib significantly improved hair loss and lesions in a patient with overlapping autoimmune disorders.

SDF-1/CXCL12 and its receptor CXCR4 are crucial for melanocyte movement in mouse hair follicles.

Nuclear Factor I-C is important for controlling hair growth by affecting the TGF-β1 pathway.

Pimecrolimus reduces the effectiveness of stem cell therapy for atopic dermatitis.

Platelet-rich fibrin may help reduce nonmelanoma skin cancer cell growth.

SCF and ET-1 together significantly increase skin pigmentation and melanin production.

Mitochondrial Complex I reduces inflammation and increases bone breakdown by affecting certain immune cells.

miR-3606-3p reduces skin fibrosis by blocking key signaling pathways.

A protein called sFRP4 from skin cells stops the development of pigment-producing cells in hair.

Patients with certain FoxN1 gene mutations have severe immune issues but normal skin and hair.

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

Increasing PBX1 reduces aging and cell death in hair follicle stem cells by boosting SIRT1 and lowering PARP1 activity.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

Circ 0020938 slows down hair growth in cashmere goats.

A new engineered treatment shows promise in curing heart fibrosis.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.

A woman with advanced eye cancer went into complete remission using a combination of immunotherapy and topical treatments.

RCS-01 therapy is safe and may improve skin structure by affecting gene expression.

NFIC helps rat dental cells grow and turn into bone-like cells.

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.

ACTH may be an effective first-line treatment for acute calcium pyrophosphate crystal arthritis.